ABBOTT/AMVAX CERTIVA 15-MONTH BOOSTER DATA FORTHCOMING; THREE-DOSE EFFICACY DATA CAN BE EXTRAPOLATED TO U.S. FOUR-DOSE SCHEDULE, ADVISORY CMTE. AGREES
Executive Summary
Safety data will be available in November for the Abbott/Amvax' Certiva diphtheria/tetanus/acellular pertussis vaccine as a fourth dose booster following three doses of whole cell pertussis vaccine, Amvax told an Oct. 29 teleconference.